5:2 Stock Split Alert: Pharma Stock Goes Ex-Trade Today; 849% Returns In 5 Years! Do You Own It?

Shares of Jagsonpal pharmaceutical stocks are going to ex- trade this morning as the stock split is scheduled today. The company, with a market capitalization of Rs. 1,687.99 crore, has announced a 5:2 stock split.

It is the last day for holding the shares of this company, as from the ex-split date onward, any new investors purchasing the stock will not be entitled to the benefits of the stock split. The extra shares that result from the split will only be allocated to shareholders who held the shares prior to the scheduled record date.

The announcement was made by the company in an exchange filing stating, "The Board of Directors of the Company has passed the necessary resolution through Circular Resolution on Tuesday, December 17, 2024, and has fixed the record date on Wednesday, January 8, 2025, for the purpose of Sub-division/Split of equity shares of the Company such that 1 (one) equity share having a face value of Rs. 5/- (Rupees five only) each, fully paid-up, be subdivided into such number of equity shares having face value of Rs. 2 (Rupee two only) each, fully paid- up"

Jagsonpal Pharmaceuticals Ltd. Stock Split History

Jagsonpal Pharmaceuticals Ltd. is undergoing its second stock split today, January 8th. Previously, the company implemented its first stock split on July 20th, 2024, reducing the face value of its shares in an effort to increase market accessibility, according to Trendlyne.

In the same period, the company also announced a bonus to reward its shareholders in the ratio 3:1 with an ex-date of July 20, 2004.

Jagsonpal Pharmaceuticals Ltd. Share Performance

On January 8th, shares of Jagsonpal Pharmaceuticals Ltd traded in the negative zone at Rs. 255.05, a decline of 2.20%. Over the past five days, the company's share price has plummeted a massive 60%, with the most significant drop occurring yesterday. In the last six months, Jagsonpal's shares have experienced a 22% decrease.

However, despite the recent downturn, the company's stock has provided an outstanding return of 849% to its investors over the last five years. Since its listing on the BSE in 1999 with an initial price of Rs. 10.48, the stock has surged by a remarkable 2,333%, indicating its impressive long-term performance on the exchanges.

Jagsonpal Pharmaceuticals Ltd. Financial performance

In Q2 FY25, the company declared a net profit of Rs. 11.46 crore for the quarter ending September 2024, up 53.41% from the same period the prior year. Quarterly sales totaled Rs. 74.69 crore, up 29.15% from Rs. 57.83 crore in the same quarter the previous year.

About Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals, an Indian pharmaceutical firm incorporated in 1972, manufactures and trades pharmaceutical goods and active pharmaceutical ingredients (APIs).

Although it is classified as a small-cap company, Jagsonpal has built a presence in the industry over the years. It offers a variety of products in the pharmaceutical and healthcare sectors, including drugs for cardiovascular, gastrointestinal, and other therapeutic areas.